Canada Pension Plan Investment Board
RETA

Canada Pension Plan Investment Board’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-156,000
Closed -$4.11M – 1635
2021
Q4 		$4.11M Buy
+156,000
New +$12.1M ﹤0.01% 741
2021
Q1 		– Sell
-2,609
Closed -$323K – 1591
2020
Q4 		$323K Buy
2,609
+447
+21% +$58.7K ﹤0.01% 1188
2020
Q3 		$211K Buy
+2,162
New +$270K ﹤0.01% 911

Other funds holding RETA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Canada Pension Plan Investment Board's RETA Position: Q1 2022 in Review

Canada Pension Plan Investment Board sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2022, closing a stake of 156,000 shares — an estimated $4.11M sold.

Canada Pension Plan Investment Board first reported a position in RETA in Q3 2020 and held it in 3 quarters. The position peaked at $4.11M in Q4 2021. 149 funds tracked by Wall St. Rank hold RETA as of Q1 2022.

  • Canada Pension Plan Investment Board reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 156,000 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2022, an estimated $4.11M.
  • Canada Pension Plan Investment Board first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2020 and held it in 3 quarters.
  • Canada Pension Plan Investment Board's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $4.11M in Q4 2021.
  • 149 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2022, filed 13 May 2022.